https://edgen.beta.edgen.tech/news/post/beta-moms-reject-hustle-culture-as-74-of-mothers-join-workforce2026-05-09T02:19:17.247Zdaily1Edgen Stocken2026-05-09T02:19:17.247+00:00Beta Moms Reject Hustle Culture as 74% of Mothers Join Workforcehttps://static.edgen.tech/news/images/beta-moms-reject-hustle-culture-as-74-of-mothers-join-workforce-20260509.pngBeta Moms Reject Hustle Culture as 74% of Mothers Join Workforce https://edgen.beta.edgen.tech/news/post/openai-presidents-2017-diary-rocks-billion-dollar-musk-lawsuit2026-05-09T02:15:12.575Zdaily1Edgen Stocken2026-05-09T02:15:12.575+00:00OpenAI President's 2017 Diary Rocks Billion-Dollar Musk Lawsuithttps://static.edgen.tech/news/images/openai-presidents-2017-diary-rocks-billion-dollar-musk-lawsuit-20260509.pngOpenAI President's 2017 Diary Rocks Billion-Dollar Musk Lawsuit https://edgen.beta.edgen.tech/news/post/desantis-trump-mend-ties-sparking-talk-of-2-cabinet-roles2026-05-09T02:14:55.273Zdaily1Edgen Stocken2026-05-09T02:14:55.273+00:00DeSantis, Trump Mend Ties, Sparking Talk of 2 Cabinet Roleshttps://static.edgen.tech/news/images/desantis-trump-mend-ties-sparking-talk-of-2-cabinet-roles-20260509.pngDeSantis, Trump Mend Ties, Sparking Talk of 2 Cabinet Roles https://edgen.beta.edgen.tech/news/post/a-new-proposal-caps-social-security-benefits-at-100000-to-avoid-a-24-cut2026-05-09T02:10:37.849Zdaily1Edgen Stocken2026-05-09T02:10:37.849+00:00A new proposal caps Social Security benefits at $100,000 to avoid a 24% cuthttps://static.edgen.tech/news/images/a-new-proposal-caps-social-security-benefits-at-100000-to-avoid-a-24-cut-20260509.pngA new proposal caps Social Security benefits at $100,000 to avoid a 24% cut https://edgen.beta.edgen.tech/news/post/tci-slashes-8-billion-microsoft-stake-on-ai-threat-boosts-alphabet2026-05-09T02:00:46.082Zdaily1Edgen Stocken2026-05-09T02:00:46.082+00:00TCI Slashes $8 Billion Microsoft Stake on AI Threat, Boosts Alphabethttps://static.edgen.tech/news/images/tci-slashes-8-billion-microsoft-stake-on-ai-threat-boosts-alphabet-20260509.pngTCI Slashes $8 Billion Microsoft Stake on AI Threat, Boosts Alphabet https://edgen.beta.edgen.tech/news/post/lumentum-stock-rallies-145-to-join-the-nasdaq-1002026-05-09T01:47:47.928Zdaily1Edgen Stocken2026-05-09T01:47:47.928+00:00Lumentum stock rallies 145% to join the Nasdaq 100https://static.edgen.tech/news/images/lumentum-stock-rallies-145-to-join-the-nasdaq-100-20260509.pngLumentum stock rallies 145% to join the Nasdaq 100 https://edgen.beta.edgen.tech/news/post/azenta-stock-plunges-25-after-slashing-full-year-guidance2026-05-09T01:42:17.263Zdaily1Edgen Stocken2026-05-09T01:42:17.263+00:00Azenta Stock Plunges 25% After Slashing Full-Year Guidancehttps://static.edgen.tech/news/images/azenta-stock-plunges-25-after-slashing-full-year-guidance-20260509.pngAzenta Stock Plunges 25% After Slashing Full-Year Guidance https://edgen.beta.edgen.tech/news/post/nike-faces-lawsuit-over-1-billion-in-tariff-refunds2026-05-09T01:41:34.316Zdaily1Edgen Stocken2026-05-09T01:41:34.316+00:00Nike faces lawsuit over $1 billion in tariff refundshttps://static.edgen.tech/news/images/nike-faces-lawsuit-over-1-billion-in-tariff-refunds-20260509.pngNike faces lawsuit over $1 billion in tariff refunds https://edgen.beta.edgen.tech/news/post/jane-street-profit-of-103-billion-in-q1-rivals-wall-street-banks2026-05-09T01:40:42.080Zdaily1Edgen Stocken2026-05-09T01:40:42.080+00:00Jane Street profit of $10.3 billion in Q1 rivals Wall Street bankshttps://static.edgen.tech/news/images/jane-street-profit-of-103-billion-in-q1-rivals-wall-street-banks-20260509.pngJane Street profit of $10.3 billion in Q1 rivals Wall Street banks https://edgen.beta.edgen.tech/news/post/senseonics-raises-2026-revenue-outlook-on-eversense-cgm-growth2026-05-09T01:40:13.877Zdaily1Edgen Stocken2026-05-09T01:40:13.877+00:00Senseonics raises 2026 revenue outlook on Eversense CGM growthhttps://static.edgen.tech/news/images/senseonics-raises-2026-revenue-outlook-on-eversense-cgm-growth-20260509.pngSenseonics raises 2026 revenue outlook on Eversense CGM growth https://edgen.beta.edgen.tech/news/post/japans-suspected-55-billion-yen-defense-unsettles-us-treasury-market2026-05-09T01:21:16.736Zdaily1Edgen Stocken2026-05-09T01:21:16.736+00:00Japan's Suspected $55 Billion Yen Defense Unsettles US Treasury Markethttps://static.edgen.tech/news/images/japans-suspected-55-billion-yen-defense-unsettles-us-treasury-market-20260509.pngJapan's Suspected $55 Billion Yen Defense Unsettles US Treasury Market https://edgen.beta.edgen.tech/news/post/monolithic-power-directors-under-investigation-stock-falls-22026-05-09T01:13:50.867Zdaily1Edgen Stocken2026-05-09T01:13:50.867+00:00Monolithic Power Directors Under Investigation, Stock Falls 2%https://static.edgen.tech/news/images/monolithic-power-directors-under-investigation-stock-falls-2-20260509.pngMonolithic Power Directors Under Investigation, Stock Falls 2% https://edgen.beta.edgen.tech/news/post/nvidia-rival-cerebras-lifts-ipo-price-to-target-38-billion2026-05-09T00:22:56.962Zdaily1Edgen Stocken2026-05-09T00:22:56.962+00:00Nvidia Rival Cerebras Lifts IPO Price to Target $3.8 Billionhttps://static.edgen.tech/news/images/nvidia-rival-cerebras-lifts-ipo-price-to-target-38-billion-20260509.pngNvidia Rival Cerebras Lifts IPO Price to Target $3.8 Billion https://edgen.beta.edgen.tech/news/post/real-brokerage-revenue-jumps-32-on-agent-growth-ahead-of-remax-deal2026-05-08T23:40:55.246Zdaily1Edgen Stocken2026-05-08T23:40:55.246+00:00Real Brokerage Revenue Jumps 32% on Agent Growth Ahead of RE/MAX Dealhttps://static.edgen.tech/news/images/real-brokerage-revenue-jumps-32-on-agent-growth-ahead-of-remax-deal-20260508.pngReal Brokerage Revenue Jumps 32% on Agent Growth Ahead of RE/MAX Deal https://edgen.beta.edgen.tech/news/post/engene-stock-plunges-76-on-bladder-cancer-drug-durability-questions2026-05-08T23:40:49.466Zdaily1Edgen Stocken2026-05-08T23:40:49.466+00:00enGene Stock Plunges 76% on Bladder Cancer Drug Durability Questionshttps://static.edgen.tech/news/images/engene-stock-plunges-76-on-bladder-cancer-drug-durability-questions-20260508.pngenGene Stock Plunges 76% on Bladder Cancer Drug Durability Questions https://edgen.beta.edgen.tech/news/post/russia-ukraine-agree-to-3-day-ceasefire-and-1000-prisoner-swap2026-05-08T23:22:19.807Zdaily1Edgen Stocken2026-05-08T23:22:19.807+00:00Russia, Ukraine Agree to 3-Day Ceasefire and 1,000-Prisoner Swaphttps://static.edgen.tech/news/images/russia-ukraine-agree-to-3-day-ceasefire-and-1000-prisoner-swap-20260508.pngRussia, Ukraine Agree to 3-Day Ceasefire and 1,000-Prisoner Swap https://edgen.beta.edgen.tech/news/post/tessera-labs-secures-60-million-to-modernize-legacy-erp-with-ai2026-05-08T22:56:39.649Zdaily1Edgen Stocken2026-05-08T22:56:39.649+00:00Tessera Labs Secures $60 Million to Modernize Legacy ERP With AIhttps://static.edgen.tech/news/images/tessera-labs-secures-60-million-to-modernize-legacy-erp-with-ai-20260508.pngTessera Labs Secures $60 Million to Modernize Legacy ERP With AI https://edgen.beta.edgen.tech/news/post/hong-kong-sfc-warns-2-firms-for-unlicensed-crypto-ipo-services2026-05-08T22:48:58.659Zdaily1Edgen Stocken2026-05-08T22:48:58.659+00:00Hong Kong SFC warns 2 firms for unlicensed crypto IPO serviceshttps://static.edgen.tech/news/images/hong-kong-sfc-warns-2-firms-for-unlicensed-crypto-ipo-services-20260508.pngHong Kong SFC warns 2 firms for unlicensed crypto IPO services https://edgen.beta.edgen.tech/news/post/quinstreet-q3-revenue-jumps-28-to-346-million-on-ai-boost2026-05-08T22:46:53.888Zdaily1Edgen Stocken2026-05-08T22:46:53.888+00:00QuinStreet Q3 revenue jumps 28% to $346 million on AI boosthttps://static.edgen.tech/news/images/quinstreet-q3-revenue-jumps-28-to-346-million-on-ai-boost-20260508.pngQuinStreet Q3 revenue jumps 28% to $346 million on AI boost https://edgen.beta.edgen.tech/news/post/humacyte-faces-investigation-from-ksf-over-fda-application-delay2026-05-08T22:46:50.047Zdaily1Edgen Stocken2026-05-08T22:46:50.047+00:00Humacyte Faces Investigation From KSF Over FDA Application Delayhttps://static.edgen.tech/news/images/humacyte-faces-investigation-from-ksf-over-fda-application-delay-20260508.pngHumacyte Faces Investigation From KSF Over FDA Application Delay